Señales en vivo de SPAGO.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 10:42):

Stats
Volumen de hoy	615 527
Volumen promedio	139 503
Capitalización de mercado	80.90M
EPS	SEK-0.0747 ( 2023-11-03 )
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-0.900
ATR14	SEK0.00600 (1.67%)

Volumen Correlación

Largo: -0.11 (neutral)

Corto: -0.59 (weak negative)

Signal:(53.663) Neutral

Spago Nanomedical AB Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Spago Nanomedical AB Correlación - Moneda/Commodity

0.62
( weak )

0.28
( neutral )

0.00
( neutral )

0.29
( neutral )

Spago Nanomedical AB Finanzas

Annual	2023
Ingresos:	SEK1.20M
Beneficio Bruto:	SEK-22.75M (-1 890.86 %)
EPS:	SEK-0.430

FY	2023
Ingresos:	SEK1.20M
Beneficio Bruto:	SEK-22.75M (-1 890.86 %)
EPS:	SEK-0.430

FY	2022
Ingresos:	SEK1.05M
Beneficio Bruto:	SEK-15.60M (-1 480.46 %)
EPS:	SEK-0.590

FY	2021
Ingresos:	SEK660 000
Beneficio Bruto:	SEK-16.78M (-2 541.82 %)
EPS:	SEK-1.430

Financial Reports:

No articles found.

Spago Nanomedical AB

Spago Nanomedical AB (publ) develops nanomedicines for cancer diagnostics and treatment primarily in Sweden. It is involved in the development of SN132D, a gadolinium-free MRI contrast agent for the treatment of breast and pancreas cancer under the SpagoPix project; and SN201, a radionuclide therapy for treatment of advanced and metastatic cancer under the Tumorad project. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. Spago Nanomedical AB (publ) was incorporated in 1999 and is based in Lund, Sweden.